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Treatment adherence 
Abstract 
Angela has been spending a fair bit of time with Sam in recent months. She is a 29-year-old single mother 
with one child. She studies part-time at the local university and has managed to maintain acceptable 
grades. She has bipolar disorder that has been well managed with medication, in different combinations 
at different pOints in her illness. However, over the last month she has intermittently missed doses and is 
consequently becoming unwell. It is puzzling that she is missing doses because she is very attached to 
her child and last time she stopped medication her daughter was placed in care. The following 
information was obtained from her in order to undertake a functional analysis. Financially, Angela was 
managing well on her supporting parent benefit and the maintenance paid by the father of her child. 
However, her former partner was sent to jail 3 months ago and the maintenance money he was sending 
her dried up. As a consequence, she started falling behind in some bills about 8 weeks ago. She has told 
you that this worries her. On top of this, her daughter started experiencing stomach aches last week and 
is cranky most of the time. Angela has said that she thinks that her daughter may be lactose intolerant 
and believes that her local GP did not take her concerns about her daughter's distress seriously enough 
when she took her to see him 10 days ago. Since becoming involved with Sam, Angela has struggled to 
keep a routine for her and her daughter and she says she forgets her medication from time to time. 
Sometimes Angela loses interest in sex and she thinks that her medication might reduce her libido. 
Angela has never received much help from her family because they don't agree with her diagnosis. He 
father says that she is just an attention getter and that she puts it on. He says that is why she cut herself 
when she was a teenager. Her father states that if she just stopped 'boozing' she wouldn't be so down and 
need the medication. Angela disagrees, stating that she has been drinking to help her sleep for years and 
is drinking no more or less now. Nonetheless, Angela has tried to cut down on her alcohol use over the 
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Enhancing Adherence to Medications 
Mitchell K. Byrne 
 
'Keep a watch also on the faults of the patients, which often make them lie about the 
taking of things prescribed’ – Hippocrates of Cos, circa 400BC 
 
Chapter Overview 
Medication is an essential tool in the clinician’s armamentarium yet it is estimated 
that 50% of patients with a chronic health condition fail to adhere to prescribed 
treatments. This chapter outlines what we mean by adherence and the implications of 
nonadherence in chronic health conditions. Difficulties in measuring adherence are 
discussed, followed by a brief review of theoretical models used to explain 
nonadherence. The chapter concludes with a discussion of the major practical issues 
that affect patient adherence and strategies for clinical intervention. 
 
Defining Adherence 
Adherence to treatment has been defined as ‘the extent to which patients follow the 
instructions they are given for prescribed treatments’ (Haynes, et al., 2005, p 2). 
Within this definition it is possible to recognise four types of adherence behaviour: 
Adoption, Consistency, Amount, and Cessation (Martin, Bowen, Dunbar-Jacob, & 
Peri, 2000). Adoption reflects the number of prescriptions filled for the patient. 
Consistency relates to how reliably the patient takes their medication on a day-to-day 
basis over a specified period of time and picks up on fluctuations in medication taking 
behaviour. Amount refers to medication taken over a cumulative period. ‘Amount’ of 
adherence can reflect great variations in behaviour in that the patient my accumulate a 
near normal dose of medication, while varying widely (both over and under dose) on 
a daily basis. Finally, cessation of medication or ‘dropout’ can reflect permanently or 
temporarily stopping medication taking. 
 
Adherence and nonadherence are not seen as polar phenomenon. Rather, adherence 
exists on a continuum from completely adherent, through levels of partial adherence, 
to not taking medication at all (Aslani & du Pasquier, 2002). In addition, both the 
form and intentionality of nonadherence may vary. For example, exceeding 
recommended doses or consuming medications in a single dose rather than spread 
across the day may be seen as nonadherence. Further, patients may vary on the degree 
of intentionality with respect to nonadherence, with some patients intending to take 
their medication as prescribed but failing to do so (due, for example, to forgetting) 
and others intending (consciously deciding) not to take their medication as prescribed 
(Aslani & du Pasquier, 2002). 
 
Nonadherence in Chronic Illness 
Within conventional medicine, the use of pharmacotherapy remains an essential 
feature of clinical practice. However, medications are only effective if they are 
appropriately used by patients. High rates of nonadherence have been observed in 
conditions as diverse as glaucoma (Kowing, Messer, Slagle & Wasik, 2010), 
hypertension (Pladevall et al., 2010) and asthma (Park et al., 2010) and is as much a 
problem for children and adolescents as it is for adults (Dean, Walters and Hall, 
2010). Across chronic medical conditions, nonadherence to prescribed medicines 
accounts for a significant proportion of treatment failure (Balkrishnan, 2005) and is 
associated with increased emergency department visits and hospitalisations (Sokol et 
al., 2005; Patel & Zed, 2002). Poor adherence is found in preventative medicine as 
well as acute and chronic health care regimens (Dunbar-Jacob, 1993) and remains a 
key predictor of relapse in major mental health disorders (Ascher-Svanum et al., 
2006). Generally, adherence rates for prescribed medicines average 50% (Cutler & 
Everett, 2010; WHO, 2003) and may cost as much as US$300 billion annually 
(Balkrishnan & Jayawant, 2007).  
 
Difficulties with adherence are pronounced in older patients who are more likely to 
experience chronic health problems, with between 70% and 80% of persons over the 
age of 65 taking at least one prescription medicine (Kaufman, Kelly, Rosenberg, 
Anderson & Mitchell, 2002). Older patients often have additional impediments to 
their adherence, such as physical and cognitive changes, which necessitate 
individually designed or tailored treatment programs (Ruppar, Conn & Russell, 2008). 
The success of efforts to promote self management of chronic health conditions needs 
to also consider to whom the patient attributes responsibility for their health care, 
which may not always be ‘the self’ (Audulv, Asplund & Norbergh, 2010). 
 
Measuring Adherence 
The measurement of adherence, particularly in clinical, ecologically valid studies, 
remains a major challenge in adherence research. It is generally agreed that there is no 
recognised ‘best method’ for assessing adherence (Byerly et al., 2007). Estimates of 
adherence by prescribing physicians have been found to be inaccurate (Roth & Caron, 
1978) as have pill counts (Morisky, Green & Levine, 1989). Physiological measures 
often reflect only recent medication taking behaviour (Urquhart, 1994). The most 
advanced method of medication monitoring to date – the Medication Events 
Monitoring System ([MEMS®], Apex Corporation, Fremont, CA) – involves an 
electronic record of each occasion the top of a medicine container is opened. 
However, this does not provide information about whether the medication is actually 
taken (Svarstad, Chewning, Sleath & Claesson, 1999). 
 
The measurement of adherence can be broadly ascribed to two categories of activity: 
objective measures of medication-taking, such as pill counts and electronic 
monitoring; and subjective measures of medication use, such as clinician ratings or 
patient questionnaire (Sajatovic, Velligan, Weiden, Valenstein & Ogedegbe, 2010). 
Adherence may also be predicted by patient attitudes and beliefs as they relate to 
treatment (Byrne, Deane & Caputi, 2008) or from their level of insight into their need 
for treatment (Byrne & Deane, in press). While there appears to be no superior 
method to gain an exact measurement of medication adherence, self-report measures, 
particularly questionnaires, are the most efficient and cost effective method of 
assessing medication adherence (Thompson Kulkarni & Sergejew, 2000). Given that 
one of the goals of adherence measurement is to identify opportunities for the 
enhancement of adherence behaviour, self report measures which include attitude and 
belief dimensions, such as the Beliefs about Medicines Questionnaire (BMQ – Horne, 
Weinman, & Hankins, 1999), may be particularly useful (Sajatovic et al., 2010).  
 
In addition to measures which identify current adherence behaviour, several recent 
measures have emerged which seek to predict which patients are likely to experience 
difficulties with adherence to treatment. For example, the ASK-20 Adherence Barrier 
Survey (Hahn et al., 2008; Matza et al., 2008) has proven useful in identifying barriers 
to adherence across a range of chronic health conditions, including asthma, 
depression, diabetes and congestive heart failure. Similarly, McHorney (2009) has 
developed the Adherence Estimator, a three-item screening instrument which enables 
healthcare providers to identify the propensity to adhere to medication among patients 
with chronic illness. Finally, Byrne and his colleagues have developed a behavioural 
rating scale which can be used to predict inpatient engagement with medications 
among psychiatric patients (Byrne, Deane, Willis, Hawkins & Quinn, 2009).  
 
Ultimately, the choice of the measure of adherence should be based not only on its 
psychometric properties, but also on its utility with respect to the researcher or 
clinicians goals (Farmer, 1999). In general, it is best that measures of adherence 
employ a continuous scale so that variations in levels of adherence can be assessed 
(Balkrishnan & Jayawant, 2007). Given that self-report as a single measure of 
adherence has unacceptably low sensitivity (Stewart, 1987), when using self report 
measures it is preferable to combine them with other sources of data or related 
domains such as clinician reports or patient attitudes (Svarstad et al., 1999). This 
might include not only multiple patient based measures, but also the ratings of 
clinicians, which have been shown to broadly concur with patient ratings (Kampman 
Lehtinen, & Lassila, 2001). 
 
Explaining Nonadherence 
The causes of nonadherence are multifaceted, but most explanatory models of 
adherence behaviour focus on the individual patient (Dunbar-Jacob, 1993). It has been 
observed that there is no consequence of nonadherence that is severe enough to ensure 
that all patients will adhere to treatment (Cramer & Rosenheck, 1998). Patient 
behaviour sometimes defies logic and common sense, however Health Psychology 
has provided a range of models of which can be used explain adherence behaviour. 
Among these, three specific models, collectively referred to as ‘Social Cognition 
Models’, seem pre-eminent: The Health Beliefs Model (HBM: Strecher, Champion, & 
Rosenstock, 1997); the Theory of Planned Behaviour (Ajzen & Fishbein, 2005); and 
the Self Regulation Model (SRM – Leventhal, Leventhal & Contrada, 1998).  
 
Health Beliefs Model (HBM) 
The HBM proposes that adherence is the result of an individual’s cost-benefit analysis 
of adherence behaviour. Further, the HBM suggests that four beliefs contribute to a 
person’s adherence behaviour: what benefits they see arising from adherence 
(‘benefits’, such as reduced symptoms); what barriers they anticipate to adherence 
(‘costs’, for example, side effects); perceived vulnerability to the illness 
(‘susceptibility’, such as the extent to which they believe that they might relapse); and 
perceived severity of the outcome (‘severity’, i.e. how bad they appraise an illness 
incident would be). Higher adherence is expected when the person sees themselves as 
more susceptible to illness, the more severe they appraise the consequences of the 
illness, the greater the expected treatment benefits and the lower the assessed barriers 
to adherence (relative to benefit). These beliefs are influenced by other variables such 
as the individual’s personality, the opinion of others and their previous experiences.  
 
Theory of Planned Behaviour (TpB) 
The fundamental premise of the TpB is that an individual’s behaviour may be 
predicted by their intentions. The intention to perform a behaviour is a function of the 
person’s attitude toward the behaviour (expected value), his/her subjective norm in 
relation to the behaviour, and the individual’s perceived ability to perform the 
behaviour, termed ‘behavioural control’. While the TpB assumes that an individual’s 
intention to behave in a given fashion is directly related to their beliefs about 
engaging in the behaviour, there is no assumption that beliefs are accurate; they may 
be biased or irrational. Once beliefs have been formed, behaviour specific attitudes 
are developed in relation to the specific behaviour, appraisals of social norms about 
the behaviour and perceptions regarding control or ability to perform the behaviour. 
Intentions to engage in the behaviour are seen to follow on from these attitudes in a 
consistent manner.  
 
Self Regulation Model 
According to the SRM, patients’ responses to illness are a function of their evaluation 
of the illness based on their own knowledge and perceptions. Central to the process of 
responding is the recognition that illness (the experience of being unwell) is different 
to disease (a condition involving diagnosed pathology). Illness is a subjective 
experience that may or may not be associated with physical pathology (disease). 
When faced with a health threat (being told that one has an illness), the individual 
must construct a personal representation of the illness. Illness representations consist 
of the patient’s own ‘common sense’ beliefs about their illness. This ‘cognitive’ level 
of illness representation is paralleled by the generation and processing of concomitant 
emotional responses.  
 
In seeking to understand nonadherence (and therefore intervene to enhance 
adherence), Social Cognition Models have identified a range of variables that relate to 
the individual. These variables, and the implications for intervention, are detailed in 
Table 1.  
 
Table 1: Variables Affecting Adherence Derived from Social Cognition Models* 
 
Variable Implication Model 
Perceived Benefit Psycho education, motivational strategies, 
strategies to enhance ‘insight’ (eg. Cognitive 
therapy) 
HBM 
Perceived Costs Motivational strategies, problem solving skills HBM 
Perceived Vulnerability Strategies to enhance insight, psycho 
education 
HBM 
Perceived Severity Psycho education, motivational strategies HBM 
Beliefs & Attitudes Psycho education, strategies to enhance 
‘insight’ or challenge irrational beliefs (such 
as cognitive therapy) 
TpB 
Normative appraisal of 
others beliefs 
Enhancement of alignment with pro-
adherence others (therapeutic alliance with 
clinician), involvement of carers, de-





Problem solving strategies, motivational 




Representation of illness 
Psycho education, strategies to enhance 
‘insight’, motivational strategies 
SRM 
* The interventions listed under “Implications” are described below. 
 
Causes of Nonadherence 
Patient factors alone do not fully explain why an individual does or does not adhere to 
treatment. Generally, four categories are used to capture the variables contributing to 
treatment adherence. These include factors associated with the treatment (such as 
complexity); factors associated with the clinician (such as skill); factors associated 
with the patient (such as insight); and factors associated with the relationship between 
clinician and therapist (McDonald, Garg & Haynes, 2002). These variables usually 




Treatment factors incorporate a broad range of variables from characteristics of the 
treatment setting through to the clarity of the prescriber’s instructions (Meichenbaum 
& Turk, 1987). More than 35 years ago, Kasl (1975) asserted that knowledge of the 
treatment regime can, in and of itself, provide information about the likelihood of 
adherence. For example, the more complex the medication regimen, the more likely it 
is that the patient will not adhere. Polypharmacy has been cited as an issue in 
adherence across chronic health conditions (DiMatteo, 2004). Simplifying medication 
regimens has proven effective in enhancing adherence in a range of chronic health 
disorders, such as glaucoma (Robin, Novack, Covert, Crocket & Marcic, 2007) and 
AIDS (Battaglioli-DeNero, 2007). It has been suggested that increasing from as few 
as one to two doses per day is enough to affect adherence (MacKean & Elkington, 
1983). 
 
There is also substantial research on the influence of side effects on adherence. Side 
effects are generally considered an issue across chronic health conditions (e.g. heart 
failure – Wu, Moser, Lennie & Burkhart, 2008; blood pressure – Elliott, 2008; and 
cancer – Faiman, 2007) and have received considerable attention in the management 
of severe mental illness (Hamer & Haddad, 2007). While it is generally accepted that 
negative side effects can reduce patient adherence and should be managed by the 
clinician (Weinmann, Janssen & Gaebel, 2005), clinicians often over estimate the 
extent to which side effects influence individual adherence decisions. Side effects are 
a relatively uncommon reason reported by patients for nonadherence (Cooper et al., 
2007) and are not a consistent predictor of adherence in research studies (Lacro et al., 
2002).  
 
Other ‘treatment’ related issues that influence adherence include accessibility, which 
refers to how easy it is to get the medications. Issues such as difficulty travelling to 
the pharmacy or doctor and not having sufficient funds to purchase the medications 
are examples of accessibility barriers to adherence. Finally, a commonly reported 
finding in chronic illness is that when patients are asymptomatic, they waiver in their 
adherence to treatment. This is often explained in terms of the difficulty relating 
treatment to illness when no symptoms are apparent or where symptoms are not ego-
dystonic. Cardiovascular disease is a good example of chronic illnesses where 
symptoms may not be detected by patients and where nonadherence to medications is 
a major challenge (Munger, Van Tassell & LaFleur, 2007).  
 
Patient Factors 
There is a substantial literature on patient related factors associated with adherence. 
This is in part due to the tendency of health researchers to focus on patient-centred 
reasons for nonadherence (Dunbar-Jacob, 1993), and because the models of health 
related behaviour, such as those reviewed above, focus on aspects of the individual. A 
consistent finding in the literature is an association between poor medication 
adherence and co-morbid substance abuse (Janssen et al., 2006). This is particularly a 
problem in severe mental health disorders, where up to 50% of patients diagnosed 
with schizophrenia meet criteria for a co-morbid diagnosis of substance abuse 
disorder (Hunt, Bergen & Bashir, 2002).  
 
Another patient related factor associated with poor adherence has been lack of insight 
into illness (McEvoy, 1998). Insight is a term associated with various meanings, both 
medical and non-medical. However, most definitions relate to an individual’s 
‘understanding’ of a given situation. While much of the research into insight has 
focussed on mental health (Amador et al., 1994), lack of insight into the need to 
maintain treatment in order to maintain health is not confined to patients with 
psychotic illnesses. For example, Shaw (2005) observes that glaucoma patients often 
need to be convinced that there is something wrong with them before they will adhere 
to preventative treatments. 
 
Poor insight has been associated with reduced help seeking behaviour, dangerousness 
to self and others, reduced treatment adherence and a generally poorer prognosis 
(Yen, Yeh, Chen, & Chung, 2002). Most frequently, it is the patient’s absence of an 
understanding that there is a need for treatment that predicts nonadherence in chronic 
illness (Buckley, Wirshing, Bhushan, Pierre, & Wirshing, 2007). Insight problems are 
likely to influence attitudes to treatment and the interplay of attitude and insight is 
important given the association between attitudes toward medication and medication 
adherence. 
 
Attitude to Medication 
Attitude to health behaviours have been central in Social Cognition Models (see 
above) and thus are salient patient factors in relation to adherence behaviour. Patients’ 
cognitions (beliefs and attitudes) can have a profound affect on treatment outcomes – 
directly through placebo (expectation that a substance or treatment will help when in 
fact it is inert) and nocebo (expectation that a substance or treatment will cause harm 
when in fact it is inert) effects and indirectly through their influence on patient 
behaviour (Horne, 2006). Clinicians should not assume that they share similar beliefs 
about medications with their patients (Ramström, Afandi, Elofsson, & Petersson, 
2006). Patients hold complex beliefs about medicines and their failure to take 
medications may be the result of ‘misguided’ beliefs (Grunfeld, Hunter, Sikka & 
Mittal, 2005).  
 
Cognitive Skills 
Cognitive skills refer to a range of memory and executive functions that allow 
humans to undertake complex behaviours. This includes planning a sequence of tasks, 
overcoming unanticipated obstacles and remembering to do things. Cognitive 
functioning can be affected by dementia, intellectual disability, substance misuse or 
the aspects of mental disorders, such as concentration and memory in depression or 
schizophrenia, (Neufeld, 2007). Cognitive skills deficits enhance the likelihood of 
nonadherence to treatment (Wallace, Dyer & Penrod, 2006) and such deficits have 
been attributed to nonadherence in a range of samples and disorders (for example, 
older adults – Mackin & Arean, 2007; chronic heart failure patients – Callegari et al., 
2002; and patients with HIV – Waldrop-Valverde et al., 2006). 
 
Motivation 
A frequently cited factor in health behaviour change is the importance of ‘patient 
motivation’ (Rollnick, Mason, & Butler, 2000) with motivation being found to be 
directly related to treatment adherence (Brondolo & Mas, 2001). Motivation has often 
mistakenly been seen as a trait or characterlogical feature of a person. However, it is 
generally accepted that motivation is more accurately construed as a state or 
situational disposition, affected by interpersonal processes and amenable to change 
(Miller & Rollnick, 2002). The improvement of motivation, through specific 
motivational enhancement techniques such as Motivational Interviewing, has 
contributed to enhanced treatment adherence in a range of studies (Bisonó, Manuel & 
Forcehimes, 2006), supporting the contention that motivation is an influential factor 
in treatment adherence. 
 
Clinician Factors    
While patient adherence to prescribed treatments may be influenced by clinician 
interventions (Petrilla, Benner, Battleman, Tierce & Hazard, 2005), not all clinicians 
actively try to enhance patient adherence using research driven methodologies 
(Ramström et al., 2006; Weinmann et al., 2005; Faris & Schopflocher, 1999; Stern et 
al., 1999). Given that medication remains an essential component of treatment of 
chronic health disorders, it could be asserted that effective implementation of 
‘adherence therapies’ would be a core activity of health clinicians. Why this is not so 
may be due to a multitude of clinician-based factors, including the clinician’s own 
competencies, attitudes and resources (Byrne, Deane & Coombs, 2005). For example, 
positive, or at least non-stigmatising attitudes towards patients are essential for the 
development of effective clinician-patient relationships (Buchanan, Rohr, Stevak, & 
Sai, 2007). However, there is no guarantee that clinicians in training hold appropriate 
attitudes toward patients, nor that they develop them as a consequence of their 
training relationships (Buchanan et al., 2007). If the clinician’s attitudes to medication 
are negative, it is likely that their ability to work effectively with patients to facilitate 
medication adherence would be compromised. 
 
Clinicians’ beliefs about their own adequacy have also been shown to influence 
intended engagement in specific professional behaviours. For example, mental health 
clinicians engagement in adherence interventions (Byrne et al, 2008), pharmacists 
delivery of medication advice and support (Farris & Schopflocher, 1999), paediatric 
providers (paediatricians and nurse-practitioners) screening of risky adolescent 
behaviours (Ozer et al., 2004), and the response by health care providers to domestic 
violence victims (Gadomski, Wolff, Trip, Lewis, & Short, 2001) are diverse examples 
where efficacy beliefs either increased or decreased the given behaviour. 
 
Brawley and Culos-Reed (2000) observe that self-efficacy beliefs are not traits of the 
individual but are sets of beliefs about specific areas of functioning. Self-efficacy 
does not relate to a quantum of skills but rather utility of possessed skills in a given 
situation. Self-efficacy can be enhanced through mastery experiences, but in the 
absence of adequate knowledge and skills training experiences, self-efficacy for a 
given behaviour can be expected to be low, reducing the likelihood of the clinician 
engaging in the desired behaviour. Thus, attention to the needs of the clinician may be 




Collaborative therapeutic relationships are essential in enhancing adherence 
(Sajatovic et al., 2005) and there is broad acceptance that the nature of the therapeutic 
relationship between the treating clinician and the patient has an important impact 
upon the outcomes of treatment (Ackerman & Hilsenroth, 2003; Horvath & Bedi, 
2002) and may even serve as a predictor of treatment outcome (Howgego, 
Yellowlees, Owen, Meldrum, & Dark, 2003). The therapeutic relationship between 
clinician and patient has been referred to as the ‘therapeutic alliance’. Both the 
behaviour of the clinician in session (Binder & Strupp, 1997) and the clinician’s 
attitudes and expectations influence the development and maintenance of the 
therapeutic alliance (Brossart, Willson, Patton, Kivlighan, & Multon, 1998). This 
perspective emphasises the importance of non-specific features of therapy (i.e. those 
unrelated to technique) as well as the need to facilitate clinician behaviours that 
promote the alliance and clinician attitudes that sustain it.  
 
Skilled use of specific activities within the therapy session may enhance the 
likelihood of developing a strong therapeutic alliance. For example, significant 
correlations have been found between poor alliance and the clinician’s failure to 
structure the session (such as through the use of an agenda), address patient resistance 
(for example by using techniques derived from motivational interviewing), adopting 
an inflexible stance (lacking a collaborative framework for intervention) and using 
destructive interventions (based on coercion) (Eaton, Abeles & Gutfreund, 1993). 
Clinicians’ attributes and behaviours that positively affect the alliance, include the 
ability to convey to the patient an adequate level of competence (with demonstrable 
self-confidence), to be responsive and empathic, and to be flexible (Ackerman & 
Hilsenroth, 2003). Furthermore, clinicians’ behaviours such as exploration, reflection 
and attending to the patient’s past experiences also supported the establishment of the 
alliance. Overall, collaborative clinician activities are usually associated with the 
deepening of the therapeutic alliance (Ackerman & Hilsenroth, 2003) 
 
Strategies for the Enhancement of Adherence 
The range of adherence interventions that have been reported in the literature fall 
broadly  into three classes or approaches: psycho educational approaches; behavioural 
strategies; and cognitive-behavioural interventions.  
 
Psycho-educational Approaches 
There is good reason to believe that enhanced patient knowledge about medications 
can play an important role in adherence, especially where the patient holds negative 
beliefs about treatment (Fernandez, Evans, Griffiths & Mostacchi, 2006). Knowledge 
can enhance insight, the patient’s appreciation of the relationship between symptoms 
and illness, treatment and recovery and thus improve motivation to adhere to 
treatment. 
 
The most successful psycho educational interventions are those that target both 
behavioural and attitudinal change. This has been demonstrated by the failure of 
numerous studies to effect significant changes in adherence or clinical functioning 
using psycho-education alone (for example Mundt, Clarke, Burroughs, BrennMan, & 
Griest, 2001). One domain that has recognised the importance of behavioural and 
attitudinal variables in the success of psycho educational strategies is that of ‘health 
literacy’. Health literacy refers to the extent to which individuals have the capacity to 
obtain, process, and understand health information and services such that they are able 
to make appropriate health decisions (Rawson et al., 2009). Lower rates health 
literacy are associated with generally poorer health status, lower use of preventative 
and screening health services, increased hospitalisation, lower adherence to treatment 
and reduced self-management of chronic illness (DeWalt, Berkman, Sheridan, Lohr & 
Pignome, 2004). According to Jorm and colleagues (1997), mental health literacy 
comprises six facets: 
 
1. Recognition of disorder 
2. Knowledge and beliefs about causes 
3. Knowledge and beliefs about self help 
4. Knowledge and beliefs about professional help 
5. Attitudes that facilitate recognition and help-seeking, and 
6. Knowledge of how to seek information  
 
Clearly in this model, attitudinal variables play an important role in a psycho-
educational model. Furthermore, both recognition of disorder and knowledge and 
beliefs about causes seem associated with insight, for which perhaps additional 
(cognitive behavioural) interventions may be necessary in order to maximise the 
benefits of psycho-educational strategies.  
 
Behavioural Interventions 
Treatment complexity has long been identified as a source of patient nonadherence 
(Haynes, 1976). It is well known that patients with problems in ‘executive function’, 
principally due to deficits in the frontal structures, particularly the pre-frontal cortex, 
experience difficulties with attention, memory, abstraction and planning (Falloon, 
Barbieri, Boggian & Lamonaca, 2007). Executive function deficits may be apparent in 
patients who are elderly, intellectually disabled, or who have chronic and severe 
mental health problems (such as depression and psychotic disorders). Given that 
different patients will have different levels of cognitive functioning (and therefore 
capacity to tolerate complex treatment regimes), a range of behavioural strategies 
have emerged to assist patients to overcome their ‘functional’ barriers to adherence. 
Unlike psycho-educational interventions, behavioural interventions are often tailored 
specifically to the needs of the individual patient, thus increasing treatment 
specificity.  
 
One of the core strategies in behavioural self-management is the use of problem 
solving techniques (Chang & D’Zurilla, 1996). Problem solving training has proven 
useful and effective for both the treatment and prevention of a wide variety of clinical 
problems (Falloon et al., 2007). Problem solving interventions aim to change both the 
individual’s ‘problem orientation’ as well as the individual’s skills at solving 
problems. Problem orientation refers to the extent to which the individual perceives 
everyday life problems as ‘solvable’ and how capable they feel at initiating problem 
solving strategies (self-efficacy). A particular strength of a problem solving approach 
is that it is amenable to the use of worksheets and templates, enabling the individual 
to experience self-efficacy and empowerment in the implementation of problem 
solving strategies. 
 
Across chronic health conditions, problem solving strategies hold additional benefits 
relevant to the enhancement of adherence, such as improving readiness to recognise 
problems (motivation), the normalisation of the experience of “problems” in life and 
the development of skills in attributing causes of problems accurately (Chang, 
Downey, & Salata, 2004). The process of problem solving also enhances the 
perception of problems as challenges as opposed to catastrophes or situations to avoid 
and offers the patient an opportunity to improve self-efficacy. 
 
Cognitive Behavioural Interventions 
Many aspects of Cognitive Behavioural Therapies (CBT) have been incorporated into 
adherence interventions. Cognitive therapy (Beck, 1964; Beck, 1995) is based on the 
precept that all psychological disorders involve the generation of dysfunctional or 
distorted thoughts and it is these thoughts which influence mood and behaviour.  
Cognitive-behavioural interventions to improve adherence aim to get patients actively 
involved in their treatment and seek to work with patients to investigate the range of 
factors that might influence medication-taking behaviour (Gray, Wykes & Gournay, 
2002). Given the apparent benefits of CBT, cognitive and behavioural approaches 
have formed the basis of most contemporary adherence programs such as Compliance 
Therapy (Kemp et al, 1996; 1998), Medication Management (Gray, Wykes, Edmonds, 
Leese, & Gournay, 2004) and more recently, Medication Alliance (Byrne, Deane, 
Lambert & Coombs, 2004; Byrne & Deane, in press). 
 
Motivational Interviewing (MI – Miller & Rollnick, 2002), which has been 
incorporated into most CBT based interventions, is a directive counselling style that is 
patient-centred and collaborative. The core strategy in MI is to assist the patient to 
understand their reasons for and against a change in behaviour and to make decisions 
about change that are intrinsically motivated. It is patient-centred as the focus is the 
concerns and perspectives of the patient, rather than the clinician. While the ‘therapy’ 
may be directive, the term ‘interviewing’ is used to capture the process of listening 
and strategic questioning rather than ‘teaching’ the patient.  
 
MI emphasises a partnership relationship between the clinician and the patient and 
seeks to elicit behaviour change within the patient by assisting them to explore and 
resolve ambivalence. Furthermore, MI stresses the importance of supporting the 
patient to generate arguments for change rather than reliance upon the clinician to 
generate such information. Essentially, MI draws upon the idea that if a person can 
talk themselves out of change, they may also talk themselves into change.  
 
The process of MI involves the identification of the patient’s goals and values and an 
awareness in the patient of the discrepancies between current behaviour, (such as 
nonadherence) and personally relevant goals. From this awareness, the patient, rather 
than the clinician, generates reasons for behaviour change (Burke, Arkowitz, & 
Menchola, 2003). Ultimately, the patient’s readiness for change is thought to stem 
from two main factors: the importance of change from the patient’s perspective and 
the patient’s confidence in their ability to engage in the change process. MI 
emphasises that the clinician must assess both importance and confidence and target 
intervention to improve both. Confidence relates directly to the patient’s self-efficacy 
and is a good predictor of treatment outcome (Burke et al., 2003).  
 
Summary and Conclusions 
The enhancement of adherence to treatment should be a core activity for all health and 
allied health professionals. There are many interventions which aim to enhance 
patient adherence and which intervention to choose should be determined from the 
individual adherence behaviours of the patient. Detailed assessment of the factors 
which predict non-adherence, with recognition of the motivational contingencies 
influencing the patient’s behaviours, is the best strategy to use in order to determine 
how to support improved adherence. This can, however, be time consuming and there 
are brief strategies that the clinician can use which will enhance adherence among a 




• Provide education about the illness and how treatment can assist: encourage 
the patient to ask questions; 
• Listen to the patient’s fears  and beliefs about treatment and correct false 
beliefs or irrational fears; 
• Check that the patient understands what has been said about the illness and 
treatment by asking them to explain their understanding of the situation; 
• Make sure all your recommendations are simple, personalised and built into 
the patient’s daily rituals. WRITE DOWN IN SIMPLIFIED TERMS WHAT 
YOU WANT THE PATIENT TO DO, WHEN, WHERE AND HOW OFTEN – 
IF POSSIBLE, SHOW THE PATIENT WHAT YOU WANT; 
• Keep the treatment as simple as possible; 
• Use as little jargon as possible & as much reflective listening to the patient as 
you can: be a team; 
• Send reminders & follow up notes (including appointment reminders), for 
example, text messages on mobile phones; 
• Communicate with other members of the health team what your treatment plan 
is so that the patient receives a consistent message; 
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